600267 Zhejiang Hisun Pharmaceutical
- 8.01
- -0.07-0.87%
Zhejiang Hisun Pharmaceutical News
Haizheng Pharmaceutical: Legal Opinion of Shanghai Junlan Law Firm on the Repurchase and Cancellation of Some Restricted Shares of the 2021 Restricted Stock Incentive Plan by Zhejiang Haizheng Pharmaceutical Co., Ltd.
Legal Opinion of Shanghai Junlan Law Firm on the Repurchase and Cancellation of Some Restricted Shares of the 2021 Restricted Stock Incentive Plan by Zhejiang Haizheng Pharmaceutical Co., Ltd.
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on the repurchase and cancellation of restricted stocks for which some incentives have been granted but sales restrictions have not yet been lifted
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on the repurchase and cancellation of some restricted shares to creditors
Zhejiang Hisun Pharmaceutical: Announcement of the first release of the restricted stock incentive plan for 2021 and the second release of the lifting of the sales restriction period and the listing of stocks of Zhejiang Hisun Pharmaceutical Co., Ltd.
Legal Opinion on the Removal of Restrictions on Zhejiang Hisun Pharmaceutical Co., Ltd.'s Restricted Stock Incentive Plan for 2021 by Shanghai Junlan Law Firm.
Announcement on the first release of the 2021 Restricted Stock Incentive Plan and the achievement of the second release restriction on Zhejiang Hisun Pharmaceutical Co., Ltd.
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on the implementation results of the third share repurchase and share changes
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on the progress of repurchasing the company's shares through centralized bidding transactions for the third time
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on the progress of repurchasing the company's shares through centralized bidding transactions for the third time
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. regarding the 2021 Restricted Stock Incentive Plan reservation grant for the first time to lift sales restrictions and release of sales restrictions and stock listing
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on the repurchase and cancellation of restricted stocks for which some incentives have been granted but sales restrictions have not yet been lifted
Legal Opinion of Shanghai Junlan Law Firm on matters relating to the repurchase and cancellation of the 2021 restricted stock incentive plan of Zhejiang Haizheng Pharmaceutical Co., Ltd.
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on the repurchase and cancellation of some restricted shares to creditors
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on the 2021 Restricted Stock Incentive Plan to reserve and grant some of the first achievements to lift the sales restriction conditions during the period of lifting the sales restrictions
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on the progress of repurchasing the company\'s shares through centralized bidding transactions for the third time
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on the progress of repurchasing the company\'s shares through centralized bidding transactions for the third time
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on the first implementation of the third plan to repurchase the company\'s shares through centralized bidding transactions
Zhejiang Haizheng Pharmaceutical Co., Ltd.\'s repurchase report on the third share repurchase through centralized bidding
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on the results of concentrated bidding for shareholders holding 5% or more of the shares to reduce their shareholding
Analysis
Price Target
No Data
No Data